Loading…

Endothelial dysfunction abrogates the efficacy of normobaric hyperoxia in stroke

Hyperoxia has been uniformly efficacious in experimental focal cerebral ischemia. However, pilot clinical trials have showed mixed results slowing its translation in patient care. To explain the discordance between experimental and clinical outcomes, we tested the impact of endothelial dysfunction,...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of neuroscience 2014-11, Vol.34 (46), p.15200-15207
Main Authors: Shin, Hwa Kyoung, Oka, Fumiaki, Kim, Ji Hyun, Atochin, Dmitriy, Huang, Paul L, Ayata, Cenk
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c513t-5dddbda913ce45767b13a6508eb66251c7853ebc658306a62abc97325e7a62fd3
cites cdi_FETCH-LOGICAL-c513t-5dddbda913ce45767b13a6508eb66251c7853ebc658306a62abc97325e7a62fd3
container_end_page 15207
container_issue 46
container_start_page 15200
container_title The Journal of neuroscience
container_volume 34
creator Shin, Hwa Kyoung
Oka, Fumiaki
Kim, Ji Hyun
Atochin, Dmitriy
Huang, Paul L
Ayata, Cenk
description Hyperoxia has been uniformly efficacious in experimental focal cerebral ischemia. However, pilot clinical trials have showed mixed results slowing its translation in patient care. To explain the discordance between experimental and clinical outcomes, we tested the impact of endothelial dysfunction, exceedingly common in stroke patients but under-represented in experimental studies, on the neuroprotective efficacy of normobaric hyperoxia. We used hyperlipidemic apolipoprotein E knock-out and endothelial nitric oxide synthase knock-out mice as models of endothelial dysfunction, and examined the effects of normobaric hyperoxia on tissue perfusion and oxygenation using high-resolution combined laser speckle and multispectral reflectance imaging during distal middle cerebral artery occlusion. In normal wild-type mice, normobaric hyperoxia rapidly and significantly improved tissue perfusion and oxygenation, suppressed peri-infarct depolarizations, reduced infarct volumes, and improved neurological function. In contrast, normobaric hyperoxia worsened perfusion in ischemic brain and failed to reduce infarct volumes or improve neurological function in mice with endothelial dysfunction. These data suggest that the beneficial effects of hyperoxia on ischemic tissue oxygenation, perfusion, and outcome are critically dependent on endothelial nitric oxide synthase function. Therefore, vascular risk factors associated with endothelial dysfunction may predict normobaric hyperoxia nonresponders in ischemic stroke. These data may have implications for myocardial and systemic circulation as well.
doi_str_mv 10.1523/jneurosci.1110-14.2014
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4228129</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1727696096</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-5dddbda913ce45767b13a6508eb66251c7853ebc658306a62abc97325e7a62fd3</originalsourceid><addsrcrecordid>eNqFkU9vEzEQxS1ERUPhK1Q-ctnU47_rCxKKUlpU0Qro2fJ6vY3Lxg72Lmq-fR21VHDiNBq9N08z80PoFMgSBGVn99HPORUXlgBAGuBLSoC_Qouq6oZyAq_RglBFGskVP0ZvS7knhCgC6g06poJpylu9QDfr2Kdp48dgR9zvyzBHN4UUse1yurOTL7iq2A9DcNbtcRpwTHmbOpuDw5v9zuf0ECwOEZcpp5_-HToa7Fj8--d6gm7P1z9WF83V9efL1aerxglgUyP6vu96q4E5z4WSqgNmpSCt76SkApxqBfOdk6JlRFpJbee0YlR4VZuhZyfo41Pubu62vnc-TtmOZpfD1ua9STaYf5UYNuYu_Tac0haorgEfngNy-jX7MpltKM6Po40-zcWAokpqSbT8v7VuzJiuT61W-WR1lU7JfnjZCIg5kDNfvq5vv11_X12aAzkD3BzI1cHTv-95GfuDij0CYF2YYw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1625339539</pqid></control><display><type>article</type><title>Endothelial dysfunction abrogates the efficacy of normobaric hyperoxia in stroke</title><source>NCBI_PubMed Central(免费)</source><creator>Shin, Hwa Kyoung ; Oka, Fumiaki ; Kim, Ji Hyun ; Atochin, Dmitriy ; Huang, Paul L ; Ayata, Cenk</creator><creatorcontrib>Shin, Hwa Kyoung ; Oka, Fumiaki ; Kim, Ji Hyun ; Atochin, Dmitriy ; Huang, Paul L ; Ayata, Cenk</creatorcontrib><description>Hyperoxia has been uniformly efficacious in experimental focal cerebral ischemia. However, pilot clinical trials have showed mixed results slowing its translation in patient care. To explain the discordance between experimental and clinical outcomes, we tested the impact of endothelial dysfunction, exceedingly common in stroke patients but under-represented in experimental studies, on the neuroprotective efficacy of normobaric hyperoxia. We used hyperlipidemic apolipoprotein E knock-out and endothelial nitric oxide synthase knock-out mice as models of endothelial dysfunction, and examined the effects of normobaric hyperoxia on tissue perfusion and oxygenation using high-resolution combined laser speckle and multispectral reflectance imaging during distal middle cerebral artery occlusion. In normal wild-type mice, normobaric hyperoxia rapidly and significantly improved tissue perfusion and oxygenation, suppressed peri-infarct depolarizations, reduced infarct volumes, and improved neurological function. In contrast, normobaric hyperoxia worsened perfusion in ischemic brain and failed to reduce infarct volumes or improve neurological function in mice with endothelial dysfunction. These data suggest that the beneficial effects of hyperoxia on ischemic tissue oxygenation, perfusion, and outcome are critically dependent on endothelial nitric oxide synthase function. Therefore, vascular risk factors associated with endothelial dysfunction may predict normobaric hyperoxia nonresponders in ischemic stroke. These data may have implications for myocardial and systemic circulation as well.</description><identifier>ISSN: 0270-6474</identifier><identifier>EISSN: 1529-2401</identifier><identifier>DOI: 10.1523/jneurosci.1110-14.2014</identifier><identifier>PMID: 25392489</identifier><language>eng</language><publisher>United States: Society for Neuroscience</publisher><subject>Animals ; Apolipoproteins E - genetics ; Apolipoproteins E - physiology ; Cerebral Cortex - blood supply ; Cerebral Cortex - pathology ; Endothelium, Vascular - enzymology ; Endothelium, Vascular - physiopathology ; Hyperoxia ; Infarction, Middle Cerebral Artery - genetics ; Infarction, Middle Cerebral Artery - metabolism ; Infarction, Middle Cerebral Artery - pathology ; Infarction, Middle Cerebral Artery - therapy ; Male ; Mice ; Mice, Knockout ; Nitric Oxide Synthase Type III - genetics ; Nitric Oxide Synthase Type III - physiology</subject><ispartof>The Journal of neuroscience, 2014-11, Vol.34 (46), p.15200-15207</ispartof><rights>Copyright © 2014 the authors 0270-6474/14/3415200-08$15.00/0.</rights><rights>Copyright © 2014 the authors 0270-6474/14/3415200-08$15.00/0 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-5dddbda913ce45767b13a6508eb66251c7853ebc658306a62abc97325e7a62fd3</citedby><cites>FETCH-LOGICAL-c513t-5dddbda913ce45767b13a6508eb66251c7853ebc658306a62abc97325e7a62fd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228129/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228129/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25392489$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shin, Hwa Kyoung</creatorcontrib><creatorcontrib>Oka, Fumiaki</creatorcontrib><creatorcontrib>Kim, Ji Hyun</creatorcontrib><creatorcontrib>Atochin, Dmitriy</creatorcontrib><creatorcontrib>Huang, Paul L</creatorcontrib><creatorcontrib>Ayata, Cenk</creatorcontrib><title>Endothelial dysfunction abrogates the efficacy of normobaric hyperoxia in stroke</title><title>The Journal of neuroscience</title><addtitle>J Neurosci</addtitle><description>Hyperoxia has been uniformly efficacious in experimental focal cerebral ischemia. However, pilot clinical trials have showed mixed results slowing its translation in patient care. To explain the discordance between experimental and clinical outcomes, we tested the impact of endothelial dysfunction, exceedingly common in stroke patients but under-represented in experimental studies, on the neuroprotective efficacy of normobaric hyperoxia. We used hyperlipidemic apolipoprotein E knock-out and endothelial nitric oxide synthase knock-out mice as models of endothelial dysfunction, and examined the effects of normobaric hyperoxia on tissue perfusion and oxygenation using high-resolution combined laser speckle and multispectral reflectance imaging during distal middle cerebral artery occlusion. In normal wild-type mice, normobaric hyperoxia rapidly and significantly improved tissue perfusion and oxygenation, suppressed peri-infarct depolarizations, reduced infarct volumes, and improved neurological function. In contrast, normobaric hyperoxia worsened perfusion in ischemic brain and failed to reduce infarct volumes or improve neurological function in mice with endothelial dysfunction. These data suggest that the beneficial effects of hyperoxia on ischemic tissue oxygenation, perfusion, and outcome are critically dependent on endothelial nitric oxide synthase function. Therefore, vascular risk factors associated with endothelial dysfunction may predict normobaric hyperoxia nonresponders in ischemic stroke. These data may have implications for myocardial and systemic circulation as well.</description><subject>Animals</subject><subject>Apolipoproteins E - genetics</subject><subject>Apolipoproteins E - physiology</subject><subject>Cerebral Cortex - blood supply</subject><subject>Cerebral Cortex - pathology</subject><subject>Endothelium, Vascular - enzymology</subject><subject>Endothelium, Vascular - physiopathology</subject><subject>Hyperoxia</subject><subject>Infarction, Middle Cerebral Artery - genetics</subject><subject>Infarction, Middle Cerebral Artery - metabolism</subject><subject>Infarction, Middle Cerebral Artery - pathology</subject><subject>Infarction, Middle Cerebral Artery - therapy</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Nitric Oxide Synthase Type III - genetics</subject><subject>Nitric Oxide Synthase Type III - physiology</subject><issn>0270-6474</issn><issn>1529-2401</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqFkU9vEzEQxS1ERUPhK1Q-ctnU47_rCxKKUlpU0Qro2fJ6vY3Lxg72Lmq-fR21VHDiNBq9N08z80PoFMgSBGVn99HPORUXlgBAGuBLSoC_Qouq6oZyAq_RglBFGskVP0ZvS7knhCgC6g06poJpylu9QDfr2Kdp48dgR9zvyzBHN4UUse1yurOTL7iq2A9DcNbtcRpwTHmbOpuDw5v9zuf0ECwOEZcpp5_-HToa7Fj8--d6gm7P1z9WF83V9efL1aerxglgUyP6vu96q4E5z4WSqgNmpSCt76SkApxqBfOdk6JlRFpJbee0YlR4VZuhZyfo41Pubu62vnc-TtmOZpfD1ua9STaYf5UYNuYu_Tac0haorgEfngNy-jX7MpltKM6Po40-zcWAokpqSbT8v7VuzJiuT61W-WR1lU7JfnjZCIg5kDNfvq5vv11_X12aAzkD3BzI1cHTv-95GfuDij0CYF2YYw</recordid><startdate>20141112</startdate><enddate>20141112</enddate><creator>Shin, Hwa Kyoung</creator><creator>Oka, Fumiaki</creator><creator>Kim, Ji Hyun</creator><creator>Atochin, Dmitriy</creator><creator>Huang, Paul L</creator><creator>Ayata, Cenk</creator><general>Society for Neuroscience</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20141112</creationdate><title>Endothelial dysfunction abrogates the efficacy of normobaric hyperoxia in stroke</title><author>Shin, Hwa Kyoung ; Oka, Fumiaki ; Kim, Ji Hyun ; Atochin, Dmitriy ; Huang, Paul L ; Ayata, Cenk</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-5dddbda913ce45767b13a6508eb66251c7853ebc658306a62abc97325e7a62fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Apolipoproteins E - genetics</topic><topic>Apolipoproteins E - physiology</topic><topic>Cerebral Cortex - blood supply</topic><topic>Cerebral Cortex - pathology</topic><topic>Endothelium, Vascular - enzymology</topic><topic>Endothelium, Vascular - physiopathology</topic><topic>Hyperoxia</topic><topic>Infarction, Middle Cerebral Artery - genetics</topic><topic>Infarction, Middle Cerebral Artery - metabolism</topic><topic>Infarction, Middle Cerebral Artery - pathology</topic><topic>Infarction, Middle Cerebral Artery - therapy</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Nitric Oxide Synthase Type III - genetics</topic><topic>Nitric Oxide Synthase Type III - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shin, Hwa Kyoung</creatorcontrib><creatorcontrib>Oka, Fumiaki</creatorcontrib><creatorcontrib>Kim, Ji Hyun</creatorcontrib><creatorcontrib>Atochin, Dmitriy</creatorcontrib><creatorcontrib>Huang, Paul L</creatorcontrib><creatorcontrib>Ayata, Cenk</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shin, Hwa Kyoung</au><au>Oka, Fumiaki</au><au>Kim, Ji Hyun</au><au>Atochin, Dmitriy</au><au>Huang, Paul L</au><au>Ayata, Cenk</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endothelial dysfunction abrogates the efficacy of normobaric hyperoxia in stroke</atitle><jtitle>The Journal of neuroscience</jtitle><addtitle>J Neurosci</addtitle><date>2014-11-12</date><risdate>2014</risdate><volume>34</volume><issue>46</issue><spage>15200</spage><epage>15207</epage><pages>15200-15207</pages><issn>0270-6474</issn><eissn>1529-2401</eissn><abstract>Hyperoxia has been uniformly efficacious in experimental focal cerebral ischemia. However, pilot clinical trials have showed mixed results slowing its translation in patient care. To explain the discordance between experimental and clinical outcomes, we tested the impact of endothelial dysfunction, exceedingly common in stroke patients but under-represented in experimental studies, on the neuroprotective efficacy of normobaric hyperoxia. We used hyperlipidemic apolipoprotein E knock-out and endothelial nitric oxide synthase knock-out mice as models of endothelial dysfunction, and examined the effects of normobaric hyperoxia on tissue perfusion and oxygenation using high-resolution combined laser speckle and multispectral reflectance imaging during distal middle cerebral artery occlusion. In normal wild-type mice, normobaric hyperoxia rapidly and significantly improved tissue perfusion and oxygenation, suppressed peri-infarct depolarizations, reduced infarct volumes, and improved neurological function. In contrast, normobaric hyperoxia worsened perfusion in ischemic brain and failed to reduce infarct volumes or improve neurological function in mice with endothelial dysfunction. These data suggest that the beneficial effects of hyperoxia on ischemic tissue oxygenation, perfusion, and outcome are critically dependent on endothelial nitric oxide synthase function. Therefore, vascular risk factors associated with endothelial dysfunction may predict normobaric hyperoxia nonresponders in ischemic stroke. These data may have implications for myocardial and systemic circulation as well.</abstract><cop>United States</cop><pub>Society for Neuroscience</pub><pmid>25392489</pmid><doi>10.1523/jneurosci.1110-14.2014</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0270-6474
ispartof The Journal of neuroscience, 2014-11, Vol.34 (46), p.15200-15207
issn 0270-6474
1529-2401
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4228129
source NCBI_PubMed Central(免费)
subjects Animals
Apolipoproteins E - genetics
Apolipoproteins E - physiology
Cerebral Cortex - blood supply
Cerebral Cortex - pathology
Endothelium, Vascular - enzymology
Endothelium, Vascular - physiopathology
Hyperoxia
Infarction, Middle Cerebral Artery - genetics
Infarction, Middle Cerebral Artery - metabolism
Infarction, Middle Cerebral Artery - pathology
Infarction, Middle Cerebral Artery - therapy
Male
Mice
Mice, Knockout
Nitric Oxide Synthase Type III - genetics
Nitric Oxide Synthase Type III - physiology
title Endothelial dysfunction abrogates the efficacy of normobaric hyperoxia in stroke
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T10%3A09%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endothelial%20dysfunction%20abrogates%20the%20efficacy%20of%20normobaric%20hyperoxia%20in%20stroke&rft.jtitle=The%20Journal%20of%20neuroscience&rft.au=Shin,%20Hwa%20Kyoung&rft.date=2014-11-12&rft.volume=34&rft.issue=46&rft.spage=15200&rft.epage=15207&rft.pages=15200-15207&rft.issn=0270-6474&rft.eissn=1529-2401&rft_id=info:doi/10.1523/jneurosci.1110-14.2014&rft_dat=%3Cproquest_pubme%3E1727696096%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c513t-5dddbda913ce45767b13a6508eb66251c7853ebc658306a62abc97325e7a62fd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1625339539&rft_id=info:pmid/25392489&rfr_iscdi=true